279 related articles for article (PubMed ID: 23146673)
1. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
[TBL] [Abstract][Full Text] [Related]
3. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
4. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
[TBL] [Abstract][Full Text] [Related]
5. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
Front Immunol; 2021; 12():720550. PubMed ID: 34733274
[TBL] [Abstract][Full Text] [Related]
6. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
[TBL] [Abstract][Full Text] [Related]
7. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
8. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
[TBL] [Abstract][Full Text] [Related]
9. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
10. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
Mangou K; Moore AJ; Thiam LG; Ba A; Orfanó A; Desamours I; Ndegwa DN; Goodwin J; Guo Y; Sheng Z; Patel SD; Diallo F; Sene SD; Pouye MN; Faye AT; Thiam A; Nunez V; Diagne CT; Sadio BD; Shapiro L; Faye O; Mbengue A; Bei AK
Sci Rep; 2022 Nov; 12(1):19403. PubMed ID: 36371450
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
[TBL] [Abstract][Full Text] [Related]
13. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
[TBL] [Abstract][Full Text] [Related]
15. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
[TBL] [Abstract][Full Text] [Related]
16. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
[TBL] [Abstract][Full Text] [Related]
17. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
[TBL] [Abstract][Full Text] [Related]
18. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331
[TBL] [Abstract][Full Text] [Related]
19. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
20. Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen.
Knudsen AS; Walker MR; Agullet JP; Björnsson KH; Bassi MR; Barfod L
Sci Rep; 2022 Feb; 12(1):3040. PubMed ID: 35197516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
